Skip to content

Assessment of Changes in Bone Mineral Metabolism After Liver Transplantation by Bone Mineral Densitometry

Assessment of Changes in Bone Mineral Metabolism After Liver Transplantation by Bone Mineral Densitometry

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07480057
Enrollment
100
Registered
2026-03-18
Start date
2026-03-18
Completion date
2026-10-30
Last updated
2026-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Liver Disease and ACLF

Brief summary

Liver transplantation (LT) remains the ultimate option to cure intractable end stage liver disease. Nutritional deficiencies are very common among CLD patients and due to this these patients suffer from low bone mineral density leading to osteoporosis and osteopenia. It has been observed that there is substantial reduction in bone density , especially within the first year of LT. The incidence of fractures among LT recipients has been reported to be around 3.5% with vertebral spine being the most common site. Multiple risk factors for osteoporosis after LT has been identified. Some of these include female sex, DM, sedentary lifestyle, pretransplant hypogonadism, Vit-D deficiency and pre-existing bone mineral abnormalities. Patients with CLD are also reported as having osteoblastic dysfunction by many factors, like unconjugated hyperbilirubinemia, decreased synthesis of collagen matrix, and decreased availability of insulin like growth factors. Post-transplant factors among LT recipients include: choice of immunosuppressive therapy like Glucocorticoid and CNIs therapy. This Observational study aims to analyze the changes in bone mineral metabolism After Liver Transplantation by Bone Mineral Densitometry preoperatively and postoperatively. All eligible adult patients with Chronic Liver Disease undergoing Liver Transplant during the study period will be included in the study. These patients bone mineral density will be assessed using DEXA scan both preop and on Post op at 3 and 6 months. The association between the changes in BMM and various variables such as the sex of the patients, age of patients, etiology of CLD, presence of hepatocellular carcinoma (HCC), ICU stay, Hospital stay will be studied. Pre-operative, intra-operative and post-operative data will be collected from medical records, electronic hospital information system (HIS) and radiological images collected from the hospital Picture archiving and communication system(PACS). The enrolled subjects will be followed up till for a period of 6 months after the Liver Transplant and the bone mineral density will be compared between these patients along with other parameters.

Interventions

OTHERno intervention

No intervention as this is an observational study

Sponsors

Institute of Liver and Biliary Sciences, India
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\- All adult patients \>18 yrs with Cirrhosis of Liver undergoing Live Donor Liver Transplant

Exclusion criteria

1. Patients not giving consent. 2. LT for ALF 3. Pediatric LT recipients 4. DDLT recipients

Design outcomes

Primary

MeasureTime frame
assessment of changes in bone mineral mass (BMM) after living donor liver transplantpreoperative and at 3 months and 6 months post LDLT

Secondary

MeasureTime frame
evaluate the association between the changes in BMM with ICU stay and Hospital staypreoperative and at 3 months and 6 months post LDLT
evaluate the association between the changes in BMM and genderpreoperative and at 3 months and 6 months post LDLT
evaluate the association between the changes in BMM and age of patientspreoperative and at 3 months and 6 months post LDLT
evaluate the association between the changes in BMM and presence of hepatocellular carcinoma (HCC)preoperative and at 3 months and 6 months post LDLT
evaluate the association between the changes in BMM and etiologypreoperative and at 3 months and 6 months post LDLT

Countries

India

Contacts

CONTACTRahul shivhare, MS
rahulshivhare93@gmail.com01146300000
CONTACTViniyendra Pamecha, FRCS
viniyendra@gmail.com01146300000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 20, 2026